AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Motheral, BR Grizzle, AJ Armstrong, EP Cox, E Fairman, K
Citation: Br. Motheral et al., Role of pharmacoeconomics in drug benefit decision-making: Results of a survey, FORMULARY, 35(5), 2000, pp. 412

Authors: Roe, CM Motheral, BR Teitelbaum, F Rich, MW
Citation: Cm. Roe et al., Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization, AM J HEAL S, 57(2), 2000, pp. 139-145

Authors: Fairman, KA Motheral, BR
Citation: Ka. Fairman et Br. Motheral, Helicobacter pylori eradication in clinical practice: Retreatment rates and costs of competing regimens, ANN PHARMAC, 34(6), 2000, pp. 721-728

Authors: Coons, SJ Motheral, BR
Citation: Sj. Coons et Br. Motheral, Quality-of-life drugs?, CLIN THER, 22(6), 2000, pp. 773-774

Authors: Coons, SJ Motheral, BR
Citation: Sj. Coons et Br. Motheral, An outpatient prescription-medication benefit in Medicare: So much time, so little consensus, CLIN THER, 22(5), 2000, pp. 639-640

Authors: Coons, SJ Motheral, BR
Citation: Sj. Coons et Br. Motheral, Pharmaceutical Economics & Health Policy - Comment, CLIN THER, 22(1), 2000, pp. 114-115

Authors: Cox, ER Motheral, BR Fairman, K
Citation: Er. Cox et al., Exhaustion of prescription benefits and Medicare beneficiaries' disenrollment from managed care, J AM MED A, 284(20), 2000, pp. 2596-2597

Authors: Motheral, BR Henderson, R
Citation: Br. Motheral et R. Henderson, The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation, AM J M CARE, 5(11), 1999, pp. 1383-1394

Authors: Motheral, BR Bataoel, JR
Citation: Br. Motheral et Jr. Bataoel, Study design - A strategy for evaluating the novel COX-2 inhibitors versusNSAIDs for arthritis, FORMULARY, 34(10), 1999, pp. 855

Authors: Motheral, BR Henderson, R
Citation: Br. Motheral et R. Henderson, The effect of a closed formulary on prescription drug use and costs, INQUIRY-J H, 36(4), 1999, pp. 481-491

Authors: Roe, CM Motheral, BR Teitelbaum, F Rich, MW
Citation: Cm. Roe et al., Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure, AM HEART J, 138(5), 1999, pp. 818-825
Risultati: 1-11 |